Download PDF
1 / Pages

Other users also viewed these articles

Is the use of secukinumab after anti-TNF therapy greater than expected for the risk of developing inflammatory bowel disease? Fatih Albayrak; Mustafa Gür; Ahmet Karata¿; Süleyman Serdar Koca; Bünyamin K¿sac¿k;
Reumatol Clin. 2024;20:123-7
Strategies and resources to optimise the management of Psoriatic Arthritis patients: The CREA Project Raquel Almodóvar; Juan D. Cañete; Eduardo Collantes; Eugenio de Miguel; Cristina Fernández Carballido; Jordi Gratacós; Xavier Juanola; José A. Pinto; Rubén Queiro; Pedro Zarco;
Reumatol Clin. 2023;19:159-67
Implementation of the recommendations for the psychological management of patients with spondyloarthritis and inflammatory bowel disease Ana Urruticoechea-Arana; Jesús Sanz; Daniel Ginard; Yago González-Lama; Xavier Juanola; Miriam Almirall; Natalia Borruel; Jordi Gratacós; Estíbaliz Loza;
Reumatol Clin. 2023;19:423-9